News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
869,809 Results
Type
Article (87958)
Company Profile (825)
Press Release (781009)
Multimedia
Podcasts (194)
Webinars (28)
Section
Business (233259)
Career Advice (4147)
Deals (39877)
Drug Delivery (150)
Drug Development (91414)
Employer Resources (205)
FDA (18386)
Job Trends (17426)
News (397908)
Policy (39969)
Tag
Academia (3010)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (145)
Alliances (56981)
ALS (180)
Alzheimer's disease (1787)
Antibody-drug conjugate (ADC) (345)
Approvals (18559)
Artificial intelligence (621)
Autoimmune disease (156)
Automation (35)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (200)
Biotechnology (490)
Bladder cancer (162)
Brain cancer (65)
Breast cancer (655)
Cancer (4993)
Cardiovascular disease (438)
Career advice (3570)
Career pathing (41)
CAR-T (302)
CDC (59)
Celiac Disease (1)
Cell therapy (821)
Cervical cancer (37)
Clinical research (76970)
Collaboration (1785)
Company closure (5)
Compensation (1147)
Complete response letters (70)
COVID-19 (2991)
CRISPR (98)
C-suite (844)
Cystic fibrosis (154)
Data (6207)
Decentralized trials (2)
Denatured (71)
Depression (150)
Diabetes (530)
Diagnostics (7218)
Digital health (44)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (299)
Drug pricing (222)
Drug shortages (36)
Duchenne muscular dystrophy (238)
Earnings (100091)
Editorial (63)
Employer branding (25)
Employer resources (173)
Events (135030)
Executive appointments (1030)
FDA (21525)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1543)
Gene editing (213)
Generative AI (63)
Gene therapy (665)
GLP-1 (1118)
Government (5437)
Grass and pollen (8)
Guidances (385)
Healthcare (20943)
HIV (60)
Huntington's disease (48)
IgA nephropathy (86)
Immunology and inflammation (289)
Immuno-oncology (57)
Indications (88)
Infectious disease (3277)
Inflammatory bowel disease (205)
Inflation Reduction Act (17)
Influenza (119)
Intellectual property (243)
Interviews (816)
IPO (17954)
IRA (60)
Job creations (5199)
Job search strategy (2866)
JPM (65)
Kidney cancer (17)
Labor market (92)
Layoffs (659)
Leadership (40)
Legal (10160)
Liver cancer (98)
Longevity (14)
Lung cancer (676)
Lymphoma (375)
Machine learning (45)
Management (66)
Manufacturing (836)
MASH (172)
Medical device (15016)
Medtech (15064)
Mergers & acquisitions (22975)
Metabolic disorders (1384)
Multiple sclerosis (161)
NASH (23)
Neurodegenerative disease (351)
Neuropsychiatric disorders (96)
Neuroscience (3095)
Neurotech (1)
NextGen: Class of 2026 (7707)
Non-profit (5110)
Now hiring (64)
Obesity (669)
Opinion (335)
Ovarian cancer (166)
Pain (204)
Pancreatic cancer (230)
Parkinson's disease (295)
Partnered (39)
Patents (498)
Patient recruitment (470)
Peanut (60)
People (66868)
Pharmaceutical (145)
Pharmacy benefit managers (32)
Phase I (23788)
Phase II (33397)
Phase III (25171)
Pipeline (4884)
Policy (333)
Postmarket research (3554)
Preclinical (10690)
Press Release (72)
Prostate cancer (242)
Psychedelics (53)
Radiopharmaceuticals (298)
Rare diseases (885)
Real estate (7439)
Recruiting (80)
Regulatory (28956)
Reports (67)
Research institute (2722)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (20)
RSV (83)
Schizophrenia (158)
Series A (256)
Series B (195)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (176)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (112)
Tariffs (99)
The Weekly (121)
Vaccines (1140)
Venture capital (94)
Weight loss (460)
Women's health (85)
Worklife (21)
Date
Today (79)
Last 7 days (346)
Last 30 days (2208)
Last 365 days (32929)
2026 (2121)
2025 (33228)
2024 (38141)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (88)
Alaska (7)
Arizona (340)
Arkansas (14)
Asia (51530)
Australia (9045)
California (11457)
Canada (3292)
China (1152)
Colorado (485)
Connecticut (497)
Delaware (343)
Europe (118389)
Florida (1673)
Georgia (368)
Hawaii (4)
Idaho (68)
Illinois (956)
India (66)
Indiana (540)
Iowa (24)
Japan (420)
Kansas (133)
Kentucky (42)
Louisiana (29)
Maine (83)
Maryland (1449)
Massachusetts (8441)
Michigan (354)
Minnesota (662)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (126)
New Hampshire (85)
New Jersey (3080)
New Mexico (33)
New York (3029)
North Carolina (1601)
North Dakota (10)
Northern California (5467)
Ohio (350)
Oklahoma (22)
Oregon (54)
Pennsylvania (2291)
Puerto Rico (21)
Rhode Island (50)
South America (1661)
South Carolina (64)
South Dakota (1)
Southern California (4424)
Tennessee (175)
Texas (1807)
United States (41345)
Utah (343)
Vermont (1)
Virginia (288)
Washington D.C. (87)
Washington State (960)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
There are 869,809 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Career Advice
Subtraction Before Addition: A Smarter Way To Set and Execute Goals
If workloads aren’t adjusted as needed, the company’s priorities are already compromised. Executive coach Angela Justice explores what happens when goals move forward without removing unnecessary work and what to do about it.
January 28, 2026
·
6 min read
·
Angela Justice
Employer Resources
Report: 2026 Employment Outlook
BioSpace
’s 2026 U.S. Life Sciences Employment Outlook examines the state of the biopharma workforce amid ongoing funding pressure, elevated layoffs and cautious hiring sentiment, while highlighting early signals of stabilization and cautious optimism for the year ahead.
January 28, 2026
·
1 min read
·
BioSpace Insights
Press Releases
Retinal Disease Expert Dr. Taiji Sakamoto Joins Kiora Pharmaceuticals’ Scientific Advisory Board
January 27, 2026
·
1 min read
Press Releases
Signios Bio Launches Xenium 5K Spatial Transcriptomics Grant Program in Collaboration with 10x Genomics
January 27, 2026
·
2 min read
Gene editing
FDA Lifts One of Two Clinical Holds on Intellia’s ATTR Gene Editing Program
After a patient safety signal and then death, the FDA in October 2025 placed holds on two of the company’s CRISPR programs for hereditary transthyretin amyloidosis.
January 27, 2026
·
2 min read
·
Dan Samorodnitsky
GLP-1
Roche’s 22% Weight Loss Benefit Seals GLP-1’s Phase III Plans, Boosts Zealand Combo
Roche said the Phase II results help build the case for advancing CT-388 into late-stage testing, which is set to get underway this quarter.
January 27, 2026
·
2 min read
·
Annalee Armstrong
Inflammatory bowel disease
Boehringer Commits up to $1.26B in IBD Pact With China’s Simcere
The cornerstone of the deal is SIM0709, which Simcere designed to target both TL1A and IL-23, crucial players in facilitating inflammation. Boehringer Ingelheim will advance the asset for inflammatory bowel diseases.
January 27, 2026
·
2 min read
·
Tristan Manalac
GLP-1
Baseline Debuts To Challenge GLP-1 Giant Lilly in Alcohol Use Disorder
While Baseline Therapeutics declined to disclose its starting capital, the startup said it will use the funds to push its GLP-1 asset BT-001 into late-stage development, with two trials planned this year.
January 27, 2026
·
2 min read
·
Tristan Manalac
Legal
CytoDyn’s Former CEO Gets Jail Time, $5.3M+ Fine for Securities Fraud
Nader Pourhassan, who led CytoDyn for nearly 10 years, was convicted in December 2024 of misleading investors regarding the biotech’s investigational COVID-19 and HIV drug, which artificially inflated its share price.
January 27, 2026
·
2 min read
·
Tristan Manalac
Press Releases
ICON’s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership
January 27, 2026
·
3 min read
1 of 86,981
Next
